Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance, Inc.    WBA

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Walgreens to Expand Drive-Through Covid-19 Testing to 15 New Sites in Seven States

share with twitter share with LinkedIn share with facebook
share via e-mail
04/07/2020 | 08:46am EDT

By Michael Dabaie

 

Walgreens said Tuesday it is working to expand drive-through Covid-19 testing to 15 new sites in seven states.

The drugstore chain said the states are Arizona, Florida, Illinois, Kentucky, Louisiana, Tennessee and Texas. Walgreens has been offering drive-thru testing in Chicago since March 21.

The new testing sites will use Abbott's ID NOW Covid-19 test, which can deliver positive results in five minutes and negative results within 13 minutes.

Walgreens said it is finalizing the 15 locations in collaboration with the U.S. Department of Health and Human Services.

Walgreens plans to be able to test up to 3,000 people per day across these additional sites, which are expected to be activated beginning later this week.

Walgreens will dedicate temporary space at some locations, outside of the stores, where Walgreens pharmacists will oversee the self-administration of the Covid-19 test. Soon, patients will be directed to testing locations via an online assessment tool that will be available on Walgreens.com and Walgreens mobile app, the company said.

Testing will be available at no cost to eligible individuals who meet criteria established by the Centers for Disease Control and Prevention. Patients will need to pre-register in advance in order to schedule an appointment for testing.

 

Write to Michael Dabaie at michael.dabaie@wsj.com

 

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -2.01% 93.01 Delayed Quote.7.08%
SPACE CO.,LTD. -1.38% 999 End-of-day quote.-21.77%
WALGREENS BOOTS ALLIANCE, INC. 0.84% 43.3 Delayed Quote.-26.56%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on WALGREENS BOOTS ALLIANCE,
05/28CVS HEALTH : tests self-driving vehicle prescription delivery
AQ
05/26Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmake..
RE
05/26Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmake..
RE
05/20WALGREENS : Honors Veterans, Active Duty Military and Families with Weekend Disc..
BU
05/20WALGREENS : Completes First Phase of Mental Health First Aid Training for Pharma..
BU
05/20Workers Push Back Against Plans To Curtail Coronavirus Hazard Pay -- WSJ
DJ
05/19Retailers Phase Out Coronavirus Hazard Pay for Essential Workers
DJ
05/19WALGREENS BOOTS ALLIANCE, INC. : Ex-dividend day for
FA
05/16Stores Stress Over How to Handle a Customer Who Won't Wear a Mask
DJ
05/12Mail-Order Drug Delivery Rises During Coronavirus Lockdowns
DJ
More news
Financials (USD)
Sales 2020 139 B - -
Net income 2020 3 601 M - -
Net Debt 2020 15 203 M - -
P/E ratio 2020 10,5x
Yield 2020 4,28%
Capitalization 37 984 M 37 984 M -
EV / Sales 2019
EV / Sales 2020 0,38x
Nbr of Employees 287 000
Free-Float 62,3%
Chart WALGREENS BOOTS ALLIANCE,
Duration : Period :
Walgreens Boots Alliance,  Technical Analysis Chart | WBA | US9314271084 | MarketScreener
Technical analysis trends WALGREENS BOOTS ALLIANCE,
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 47,11 $
Last Close Price 43,30 $
Spread / Highest target 29,3%
Spread / Average Target 8,79%
Spread / Lowest Target -5,31%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
James Kehoe Global Chief Financial Officer & Executive VP
Sector and Competitors